Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Reply to '12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy'.

Hoevelmann J, Viljoen CA, Millar RS, Manning K, Ntsekhe M, Sliwa K.

Int J Cardiol. 2019 Aug 6. pii: S0167-5273(19)32395-2. doi: 10.1016/j.ijcard.2019.08.014. [Epub ahead of print] No abstract available.

PMID:
31431295
2.

Recurrent idiopathic spontaneous coronary artery dissection.

Mkoko P, Pandie S, Ntsekhe M.

S Afr Med J. 2019 Jun 28;109(7):477-479. doi: 10.7196/SAMJ.2019.v109i7.13997.

PMID:
31266572
3.

Healthy Hearts: A student-led heart-health initiative.

Seedat A, Viljoen CA, Islam M, Kim M, Ntusi NAB, Ntsekhe M.

S Afr Med J. 2019 Jun 28;109(7):450-451. doi: 10.7196/SAMJ.2019.v109i7.14101. No abstract available.

PMID:
31266567
4.

Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study.

Shenje J, Gumbo T, Wiesner L, Ntsekhe M, Mayosi B, Ross I.

Int J Cardiol Heart Vasc. 2019 Jan 11;22:105-110. doi: 10.1016/j.ijcha.2018.12.008. eCollection 2019 Mar.

5.

The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.

Ndadza A, Thomford NE, Mukanganyama S, Wonkam A, Ntsekhe M, Dandara C.

OMICS. 2019 Mar;23(3):152-166. doi: 10.1089/omi.2019.0018.

PMID:
30883300
6.

The Groote Schuur Cardiac Clinic: A centre of cardiovascular excellence at the tip of the African Continent.

Cupido B, Ntsekhe M.

Eur Heart J. 2019 Feb 1;40(5):406-408. doi: 10.1093/eurheartj/ehy864. No abstract available.

PMID:
30715284
7.

TAVI for rheumatic aortic stenosis - The next frontier?

Ntsekhe M, Scherman J.

Int J Cardiol. 2019 Apr 1;280:51-52. doi: 10.1016/j.ijcard.2019.01.015. Epub 2019 Jan 7. No abstract available.

PMID:
30658925
8.

Warfarin Dose and CYP2C Gene Cluster: An African Ancestral-Specific Variant Is a Strong Predictor of Dose in Black South African Patients.

Ndadza A, Cindi Z, Makambwa E, Chimusa E, Wonkam A, Kengne AP, Ntsekhe M, Dandara C.

OMICS. 2019 Jan;23(1):36-44. doi: 10.1089/omi.2018.0174. Epub 2018 Dec 19.

PMID:
30566377
9.

Bongani Mayosi, 1967-2018.

Schwartz PJ, Ntsekhe M.

Eur Heart J. 2018 Dec 7;39(46):4051-4061. doi: 10.1093/eurheartj/ehy715. No abstract available.

PMID:
30535016
10.

The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy.

Hoevelmann J, Viljoen CA, Manning K, Baard J, Hahnle L, Ntsekhe M, Bauersachs J, Sliwa K.

Int J Cardiol. 2019 Feb 1;276:177-184. doi: 10.1016/j.ijcard.2018.11.008. Epub 2018 Nov 7.

PMID:
30497895
11.

Epidemiology of pericardial diseases in Africa: a systematic scoping review.

Noubiap JJ, Agbor VN, Ndoadoumgue AL, Nkeck JR, Kamguia A, Nyaga UF, Ntsekhe M.

Heart. 2019 Feb;105(3):180-188. doi: 10.1136/heartjnl-2018-313922. Epub 2018 Nov 10.

PMID:
30415206
12.

Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis.

Ramasamy V, Mayosi BM, Sturrock ED, Ntsekhe M.

World J Cardiol. 2018 Sep 26;10(9):87-96. doi: 10.4330/wjc.v10.i9.87. Review.

13.

Invasive cardiovascular needs in South Africa: a view from afar up close.

Holmes DR Jr, King S, Gershlick AH, Marco J, Koolen J, Pichard A, Bassand JP, Kettles DI, Wijns W, Ntsekhe M.

EuroIntervention. 2018 Oct 20;14(8):852-855. doi: 10.4244/EIJV14I8A153. No abstract available.

14.

Bongani Mayosi, a hero remembered.

Ntsekhe M, Commerford P, Brink P, Yusuf S.

Cardiovasc J Afr. 2018 Jul/Aug;29(4):206. No abstract available.

15.

Corticosteroids as an adjunct to tuberculosis therapy.

Schutz C, Davis AG, Sossen B, Lai RP, Ntsekhe M, Harley YX, Wilkinson RJ.

Expert Rev Respir Med. 2018 Oct;12(10):881-891. doi: 10.1080/17476348.2018.1515628. Epub 2018 Sep 6. Review.

PMID:
30138039
16.

Reducing late maternal death due to cardiovascular disease - A pragmatic pilot study.

Sliwa K, Azibani F, Baard J, Osman A, Zühlke L, Lachmann A, Libhaber E, Chin A, Ntsekhe M, Soma-Pillay P, Johnson MR, Roos-Hesselink J, Anthony J.

Int J Cardiol. 2018 Dec 1;272:70-76. doi: 10.1016/j.ijcard.2018.07.140. Epub 2018 Aug 3.

PMID:
30087040
17.

Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.

Kengne AP, Ntsekhe M.

Circulation. 2018 May 22;137(21):2215-2217. doi: 10.1161/CIRCULATIONAHA.118.033913. No abstract available.

PMID:
29784678
18.

Effect of prednisolone on inflammatory markers in pericardial tuberculosis: A pilot study.

Shenje J, Lai RP, Ross IL, Mayosi BM, Wilkinson RJ, Ntsekhe M, Wilkinson KA.

Int J Cardiol Heart Vasc. 2017 Nov 3;18:104-108. doi: 10.1016/j.ijcha.2017.10.002. eCollection 2018 Mar.

19.

Step-by-step manual for planning and performing bifurcation PCI: a resource-tailored approach.

Milasinovic D, Wijns W, Ntsekhe M, Hellig F, Mohamed A, Stankovic G.

EuroIntervention. 2018 Feb 2;13(15):e1804-e1811. doi: 10.4244/EIJ-D-17-00580. Review.

20.

Interventions for treating tuberculous pericarditis.

Wiysonge CS, Ntsekhe M, Thabane L, Volmink J, Majombozi D, Gumedze F, Pandie S, Mayosi BM.

Cochrane Database Syst Rev. 2017 Sep 13;9:CD000526. doi: 10.1002/14651858.CD000526.pub2. Review.

21.

Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure.

Chin A, Ntsekhe M, Viljoen C, Rossouw J, Pennel T, Schwartz PJ.

Int J Cardiol. 2017 Dec 1;248:227-231. doi: 10.1016/j.ijcard.2017.08.012. Epub 2017 Aug 8.

PMID:
28864134
22.
23.

Cardiovascular disease in Africa: epidemiological profile and challenges.

Keates AK, Mocumbi AO, Ntsekhe M, Sliwa K, Stewart S.

Nat Rev Cardiol. 2017 May;14(5):273-293. doi: 10.1038/nrcardio.2017.19. Epub 2017 Feb 23. Review.

PMID:
28230175
24.
25.

Tuberculosis and the Heart.

Mutyaba AK, Ntsekhe M.

Cardiol Clin. 2017 Feb;35(1):135-144. doi: 10.1016/j.ccl.2016.08.007. Review.

PMID:
27886784
26.

Cardiology-cardiothoracic subspeciality training in South Africa: a position paper of the South Africa Heart Association.

Sliwa K, Zühlke L, Kleinloog R, Doubell A, Ebrahim I, Essop M, Kettles D, Jankelow D, Khan S, Klug E, Lecour S, Marais D, Mpe M, Ntsekhe M, Osrin L, Smit F, Snyders A, Theron JP, Thornton A, Chin A, van der Merwe N, Dau E, Sarkin A.

Cardiovasc J Afr. 2016 May/Jun;27(3):188-193. doi: 10.5830/CVJA-2016-063.

27.

Cardio-Thoracic Ratio Is Stable, Reproducible and Has Potential as a Screening Tool for HIV-1 Related Cardiac Disorders in Resource Poor Settings.

Esmail H, Oni T, Thienemann F, Omar-Davies N, Wilkinson RJ, Ntsekhe M.

PLoS One. 2016 Oct 4;11(10):e0163490. doi: 10.1371/journal.pone.0163490. eCollection 2016.

28.

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis.

Pandie S, Peter JG, Kerbelker ZS, Meldau R, Theron G, Govender U, Ntsekhe M, Dheda K, Mayosi BM.

Sci Rep. 2016 Sep 16;6:32924. doi: 10.1038/srep32924.

29.

Approach to chest pain and acute myocardial infarction.

Pandie S, Hellenberg D, Hellig F, Ntsekhe M.

S Afr Med J. 2016 Mar;106(3):239-45.

PMID:
27303759
30.

Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis.

Shenje J, Ifeoma Adimora-Nweke F, Ross IL, Ntsekhe M, Wiesner L, Deffur A, McIlleron HM, Pasipanodya J, Gumbo T, Mayosi BM.

EBioMedicine. 2015 Sep 16;2(11):1640-9. doi: 10.1016/j.ebiom.2015.09.025. eCollection 2015 Nov.

31.

Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality.

Pasipanodya JG, Mubanga M, Ntsekhe M, Pandie S, Magazi BT, Gumedze F, Myer L, Gumbo T, Mayosi BM.

EBioMedicine. 2015 Sep 21;2(11):1634-9. doi: 10.1016/j.ebiom.2015.09.034. eCollection 2015 Nov.

32.

Management of pulmonary hypertension.

Essop MR, Galie N, Badesch DB, Lalloo U, Mahomed AG, Naidoo DP, Ntsekhe M, Williams PG.

S Afr Med J. 2015 Jun;105(6):437-9.

PMID:
26716153
33.

A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.

Matthews K, Deffur A, Ntsekhe M, Syed F, Russell JB, Tibazarwa K, Wolske J, Brink J, Mayosi BM, Wilkinson RJ, Wilkinson KA.

Am J Respir Crit Care Med. 2015 Dec 15;192(12):1518-21. doi: 10.1164/rccm.201504-0683LE. No abstract available.

34.

A lady with a broken heart: Apical ballooning syndrome.

Rush C, Ntsekhe M.

S Afr Med J. 2015 Apr 10;105(5):422. doi: 10.7196/samj.9603.

PMID:
26242680
35.

Digoxin therapy in the modern management of cardiovascular disease: An unusual but serious complication.

Mkoko P, Mokhele N, Ntsekhe M, Ntusi NA.

S Afr Med J. 2014 Dec 16;105(2):154. doi: 10.7196/samj.8638. No abstract available.

PMID:
26242507
36.

Immunotherapy for tuberculous pericarditis.

Mayosi BM, Ntsekhe M, Smieja M.

N Engl J Med. 2014 Dec 25;371(26):2534. doi: 10.1056/NEJMc1413185. No abstract available.

PMID:
25539114
37.

Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.

Griffiths B, Lesosky M, Ntsekhe M.

S Afr Med J. 2014 Jun 17;104(7):483-7. doi: 10.7196/samj.7798.

PMID:
25214049
38.

Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.

Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, Joldersma L, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Chitsa Banda A, Brown B, Manga P, Kirenga B, Mondo C, Mntla P, Tsitsi JM, Peters F, Essop MR, Russell JB, Hakim J, Matenga J, Barasa AF, Sani MU, Olunuga T, Ogah O, Ansa V, Aje A, Danbauchi S, Ojji D, Yusuf S; IMPI Trial Investigators.

N Engl J Med. 2014 Sep 18;371(12):1121-30. doi: 10.1056/NEJMoa1407380. Epub 2014 Sep 1.

39.

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.

Pandie S, Peter JG, Kerbelker ZS, Meldau R, Theron G, Govender U, Ntsekhe M, Dheda K, Mayosi BM.

BMC Med. 2014 Jun 18;12:101. doi: 10.1186/1741-7015-12-101.

40.

Myopericarditis in tuberculous pericardial effusion: prevalence, predictors and outcome.

Syed FF, Ntsekhe M, Gumedze F, Badri M, Mayosi BM.

Heart. 2014 Jan;100(2):135-9. doi: 10.1136/heartjnl-2013-304786. Epub 2013 Nov 19.

PMID:
24254192
41.

Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.

Ntsekhe M, Matthews K, Syed FF, Deffur A, Badri M, Commerford PJ, Gersh BJ, Wilkinson KA, Wilkinson RJ, Mayosi BM.

PLoS One. 2013 Oct 14;8(10):e77532. doi: 10.1371/journal.pone.0077532. eCollection 2013.

42.
43.

Recent advances in the epidemiology, outcome, and prevention of myocardial infarction and stroke in sub-Saharan Africa.

Ntsekhe M, Damasceno A.

Heart. 2013 Sep;99(17):1230-5. doi: 10.1136/heartjnl-2012-303585. Epub 2013 May 16. Review.

PMID:
23680888
44.

Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

Mayosi BM, Ntsekhe M, Bosch J, Pogue J, Gumedze F, Badri M, Jung H, Pandie S, Smieja M, Thabane L, Francis V, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Banda AC, Mutyaba A, Brown B, Ntuli P, Mntla P, Ntyintyane L, Ramjee R, Manga P, Kirenga B, Mondo C, Russell JB, Tsitsi JM, Peters F, Essop MR, Barasa AF, Mijinyawa MS, Sani MU, Olunuga T, Ogah O, Adebiyi A, Aje A, Ansa V, Ojji D, Danbauchi S, Hakim J, Matenga J, Yusuf S.

Am Heart J. 2013 Feb;165(2):109-15.e3. doi: 10.1016/j.ahj.2012.08.006. Epub 2012 Dec 13.

PMID:
23351812
45.

Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction.

Ntsekhe M, Matthews K, Wolske J, Badri M, Wilkinson KA, Wilkinson RJ, Sturrock ED, Mayosi BM.

Heart. 2012 Sep;98(17):1326-8. doi: 10.1136/heartjnl-2012-302196. Epub 2012 Jul 26. No abstract available.

46.

Quantification of echodensities in tuberculous pericardial effusion using fractal geometry: a proof of concept study.

Ntsekhe M, Mayosi BM, Gumbo T.

Cardiovasc Ultrasound. 2012 Jul 28;10:30. doi: 10.1186/1476-7120-10-30.

47.

Atrial fibrillation as a consequence of tuberculous pericardial effusion.

Syed FF, Ntsekhe M, Wiysonge CS, Badri M, Oh JK, Mayosi BM.

Int J Cardiol. 2012 Jun 28;158(1):152-4. doi: 10.1016/j.ijcard.2012.04.075. Epub 2012 May 14. No abstract available.

PMID:
22592033
48.

Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome.

Kenyon C, Schrueder N, Ntsekhe M, Meintjes G.

Cardiovasc J Afr. 2012 Apr 12;23(3):e14-7. doi: 10.5830/CVJA-2011-062.

49.

Tuberculous pericarditis with and without HIV.

Ntsekhe M, Mayosi BM.

Heart Fail Rev. 2013 May;18(3):367-73. doi: 10.1007/s10741-012-9310-6. Review.

PMID:
22427006
50.

Effusive-constrictive pericarditis.

Syed FF, Ntsekhe M, Mayosi BM, Oh JK.

Heart Fail Rev. 2013 May;18(3):277-87. doi: 10.1007/s10741-012-9308-0. Review.

PMID:
22422296

Supplemental Content

Loading ...
Support Center